Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leo Rasche

Showing results (1-10 of 170) with videos related to

Pageof 17
Sort By:
Blood|October 9, 2025
Unlocking myeloma's spatial world at the micrometer scaleLeo Rasche, Niels Weinhold
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 24, 2024
The Difficulty in Defining the True High-Risk Smoldering MyelomaNiels Weinhold, Leo Rasche
Blood|November 30, 2023
When a solitary plasmacytoma is just the beginning…Leo Rasche, Niels Weinhold
Blood|December 19, 2024
BCMA bispecifics: breaking the chains of resistanceJohannes M Waldschmidt, Leo Rasche
Nature Reviews. Clinical Oncology|June 14, 2017
Haematological cancer: Where are we now with the treatment of multiple myeloma?Gareth J Morgan, Leo Rasche
Expert Review of Hematology|June 27, 2018
Maintaining therapeutic progress in multiple myeloma by integrating genetic and biological advances into the clinicGareth J Morgan, Leo Rasche
Blood|November 30, 2023
CAR T-cell therapy in multiple myeloma: mission accomplished?Leo Rasche, Michael Hudecek, Hermann Einsele
Blood|August 1, 2020
What is the future of immunotherapy in multiple myeloma?Leo Rasche, Michael Hudecek, Hermann Einsele
Deutsche Medizinische Wochenschrift (1946)|May 31, 2022
[Monoclonal gammopathy of (un)known significance]Maximilian Steinhardt, Martin Kortüm, Hermann Einsele, et al.
Current Opinion in Hematology|July 10, 2009
Cellular therapy to control tumor progressionMarkus Kapp, Leo Rasche, Hermann Einsele, et al.
Pageof 17

Showing results (1-10 of 170) with videos related to

Sort By:
Pageof 17
Blood|October 9, 2025
Unlocking myeloma's spatial world at the micrometer scaleLeo Rasche, Niels Weinhold
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 24, 2024
The Difficulty in Defining the True High-Risk Smoldering MyelomaNiels Weinhold, Leo Rasche
Blood|November 30, 2023
When a solitary plasmacytoma is just the beginning…Leo Rasche, Niels Weinhold
Blood|December 19, 2024
BCMA bispecifics: breaking the chains of resistanceJohannes M Waldschmidt, Leo Rasche
Nature Reviews. Clinical Oncology|June 14, 2017
Haematological cancer: Where are we now with the treatment of multiple myeloma?Gareth J Morgan, Leo Rasche
Expert Review of Hematology|June 27, 2018
Maintaining therapeutic progress in multiple myeloma by integrating genetic and biological advances into the clinicGareth J Morgan, Leo Rasche
Blood|November 30, 2023
CAR T-cell therapy in multiple myeloma: mission accomplished?Leo Rasche, Michael Hudecek, Hermann Einsele
Blood|August 1, 2020
What is the future of immunotherapy in multiple myeloma?Leo Rasche, Michael Hudecek, Hermann Einsele
Deutsche Medizinische Wochenschrift (1946)|May 31, 2022
[Monoclonal gammopathy of (un)known significance]Maximilian Steinhardt, Martin Kortüm, Hermann Einsele, et al.
Current Opinion in Hematology|July 10, 2009
Cellular therapy to control tumor progressionMarkus Kapp, Leo Rasche, Hermann Einsele, et al.
Pageof 17